Drug intelligence / Profile preview

Exovex

Development stage
Preclinical
Lead developer
ExoCel Bio
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Exovex is an exosome-based regenerative medicine product developed by ExoCel Bio, derived from mesenchymal stem cells (MSCs) of the human placental chorion layer. It is a non-lyophilized biologic containing a concentrated payload of mRNA, microRNA, peptide growth factors, and signaling cytokines. The product is designed for topical application following aesthetic procedures such as microneedling, laser resurfacing, and chemical peels to accelerate tissue recovery and enhance cosmetic outcomes. It is also utilized in the management of androgenetic alopecia and skin rejuvenation (addressing fine lines, wrinkles, and skin texture). Exovex is available in several formulations—Revive, Renew, Reveal, Restore, Refine, and Rejuv—which differ in their exosome concentration, ranging from 1 billion to 75 billion exosomes per vial.

Brand names
ExovexExovex ReviveExovex RenewExovex RevealExovex RestoreExovex RefineExovex Rejuv

Beyond the preview

Go deeper on Exovex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exovex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call